Top 5 Promising Companies To Own For 2016

Stocks fell hard today, pushing the S&P 500 and Nasdaq Composite into the red for the week.

Reuters

The S&P 500 fell 0.2% to 2,096.07 this week after falling 0.9% today, while the Dow Jones Industrial Average rose 0.3% to 17,865.34 this week after declined 119.85 points, or 0.7%, today. The Nasdaq Composite dropped 1% this week after sliding 1.3% to 4,894.55 today.

BMO Capital Market’s Brian Belski and team argue that 2016 could be “bumpy.” They explain:

Prices are rarely linear for long, and US stocks are overdue for a respite. As such, we believe the changing tone of monetary policy, continued China/EM strife, and commodity uncertainty will force investors to accept the realities of fundamental investing as they struggle with the transition away from strategies that have depended on quantitative easingbiased returns, momentum, and macro analysis.

Top 5 Promising Companies To Own For 2016: Outerwall Inc.(OUTR)

 

Outerwall Inc., through its subsidiaries, provides automated retail solutions primarily in the United States, Canada, Puerto Rico, Ireland, and the United Kingdom. Its Redbox segment owns and operates approximately 40,480 Redbox kiosks in 33,060 locations that enable consumers to rent or purchase movies and video games. The companys Coinstar segment owns and operates approximately 20,930 coin-counting kiosks in 19,660 locations, which enable consumers to convert their coin to cash, convert coins and paper bills to stored value products, and exchange gift cards for cash. The companys ecoATM segment owns and operates approximately 2,250 kiosks in 2,020 locations that enable consumers to purchase and sell electronic devices for cash at self-service kiosks. Its ecoATM segment also operates gazelle.com, a direct-to-consumer online solution for the purchase and sale of certain electronic devices for cash. The companys other co ncepts and investments include identifying, evaluating, building, acquiring, and developing self-service concepts in the automated retail space. The company was formerly known as Coinstar, Inc. and changed its name to Outerwall Inc. in June 2013. Outerwall Inc. was founded in 1991 and is headquartered in Bellevue, Washington.

Advisors’ Opinion:

  • [By Monica Gerson]

    Shares of Outerwall Inc (NASDAQ: OUTR) surged over 8 percent in Monday’s after-hours trading session following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall’s Board also announced the raising of the company’s quarterly dividend from $0.30 to $0.60 per share. Outerwall shares jumped 8.11 percent to $37.18 in the after-hours trading session.

  • [By Monica Gerson]

    Outerwall (NASDAQ: OUTR) lowered its forecast for the third quarter and full year. Outerwall shares dipped 19.96% to $44.80 in after-hours trading.

  • [By Lisa Levin]

    Outerwall (NASDAQ: OUTR) plummeted 12.08% to $49.21 after the company lowered its forecast for the third quarter and full year.

    JinkoSolar Holding Co (NYSE: JKS) dropped 9.88% to $16.87 after the company announced the offering of 3,500,000 American Depositary Shares.

Top 5 Promising Companies To Own For 2016: International Business Machines Corporation(IBM)

International Business Machines Corporation (IBM) provides information technology (IT) products and services worldwide. Its Global Technology Services segment provides IT infrastructure and business process services, including strategic outsourcing, process, integrated technology, and maintenance services, as well as technology-based support services. The company?s Global Business Services segment offers consulting and systems integration, and application management services. Its Software segment offers middleware and operating systems software, such as WebSphere software to integrate and manage business processes; information management software for database and enterprise content management, information integration, data warehousing, business analytics and intelligence, performance management, and predictive analytics; Tivoli software for identity management, data security, storage management, and datacenter automation; Lotus software for collaboration, messaging, and so cial networking; rational software to support software development for IT and embedded systems; business intelligence software, which provides querying and forecasting tools; SPSS predictive analytics software to predict outcomes and act on that insight; and operating systems software. Its Systems and Technology segment provides computing and storage solutions, including servers, disk and tape storage systems and software, point-of-sale retail systems, and microelectronics. The company?s Global Financing segment provides lease and loan financing to end users and internal clients; commercial financing to dealers and remarketers of IT products; and remanufacturing and remarketing services. It serves financial services, public, industrial, distribution, communications, and general business sectors. The company was formerly known as Computing-Tabulating-Recording Co. and changed its name to International Business Machines Corporation in 1924. IBM was founded in 1910 and is base d in Armonk, New York.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Lost amid all the talk of a new Glass-Steagall in the Republican platform is the fact that the party also wants to make it easier for companies like International Business Machines (IBM), Pfizer (PFE), Dow Chemical (DOW), Cisco Systems (CSCO), and Merck (MRK) to repatriate their foreign profits. Strategas Research Partners’ Daniel Clifton and team discuss:

Top Consumer Service Companies To Own For 2016: Medidata Solutions, Inc.(MDSO)

 

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company offers applications and data analytics for clinical development. It offers Medidata Rave, a platform for capturing, managing, and reporting clinical data; Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, which enhances the efficiency of clinical trial start-up; Medidata Insights, a clinical business analytics platform; and Medidata Balance, a randomization and trial supply management solution. The company also provides Medidata Patient Cloud application for electronic patient-reported outcome; Medidata Grants Manager, which enables to develop and manage trial budgets; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and Medidata SQM, a set of c loud-based site quality management dashboards. In addition, it offers Medidata Coder that provides medical coding and synonym management solutions; Medidata Safety Gateway, which offers a solution for collecting and transmitting adverse events and related data from the EDC system; and Medidata Targeted SDV that provides auditable and scalable solutions, as well as offers hosting, support, and professional services. Medidata Solutions, Inc. markets and sells its cloud-based solutions through direct sales force, as well as through relationships with CROs and other strategic partners. The company serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and academic institutions, contract research organizations, and other entities engaged in clinical trials. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Advisors’ Opinion:

  • [By Lisa Levin]

    On Wednesday, technology shares climbed by 0.94 percent. Top gainers in the sector included Marvell Technology Group Ltd. (NASDAQ: MRVL) and Medidata Solutions Inc (NASDAQ: MDSO).

Top 5 Promising Companies To Own For 2016: Pharmerica Corporation(PMC)

Pharmerica Corporation operates as an institutional pharmacy services company in the United States. It offers services to healthcare facilities and provides management pharmacy services to hospitals. The company purchases, repackages, and dispenses prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers such medication to healthcare facilities for administration to individual patients and residents. It also provides consultant pharmacist services for customers to comply with the federal and state regulations applicable to nursing homes; and medical records services. In addition, the company offers various ancillary services, such as infusion therapy products and services; and hospital pharmacy management services, including hospital pharmacy operations, regulatory and financial management services, and clinical pharmacy programs to various hospitals. PharMerica Corporation operates approximately 95 institutional pharmacies in 44 s tates and provides pharmacy management services to 91 hospitals. Its customers primarily include institutional healthcare providers, such as skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and other long-term alternative care settings. The company is headquartered in Louisville, Kentucky.

Advisors’ Opinion:

  • [By Monica Gerson]

    PharMerica Corporation (NYSE: PMC) is estimated to report its quarterly earnings at $0.43 per share on revenue of $509.45 million.

    United States Cellular Corp (NYSE: USM) is projected to report its quarterly earnings at $0.26 per share on revenue of $975.54 million.

Top 5 Promising Companies To Own For 2016: Synta Pharmaceuticals Corp.(SNTA)

 

Synta Pharmaceuticals Corp. focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. Its clinical stage drug candidate in oncology is ganetespib, an Hsp90 inhibitor, which is in Phase II clinical trials to evaluate the combination of ganetespib and paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer; and in Phase I/II trial in combination with the mTOR inhibitor sirolimus in patients with refractory sarcoma, including malignant peripheral nerve sheath tumors. The companys drug candidate in its Hsp90-inhibitor Drug Conjugate program is STA-12-8666, which is in preclinical trials for chemotherapy irinotecan. Synta Pharmaceuticals Corp. was incorporated in 2000 and is based in Lexington, Massachusetts.

Advisors’ Opinion:

  • [By Lisa Levin]

    Synta Pharmaceuticals Corp. (NASDAQ: SNTA) shares were also up, gaining 61 percent to $0.393. Synta Pharmaceuticals announced plans to merge with privately-held Madrigal Pharmaceuticals.